Spinal Cord Injury Investor Symposium: Lineage Cell Therapeutics' CEO Brian Culley describes the idea behind the conference and gives an overview of his company's cell therapy approach

Brian Culley describes the need for an spinal cord injury focused investor conference and how the SCI Investor Symposium has grown over time. He also gives an overview of Lineage Cell's cell therapy approach to this field.